Deleterious mutation V369M in the mouse GCGR gene causes abnormal plasma amino acid levels indicative of a possible liver-α-cell axis

Biosci Rep. 2021 Jun 25;41(6):BSR20210758. doi: 10.1042/BSR20210758.

Abstract

Glucagon plays an important role in glucose homeostasis and amino acid metabolism. It regulates plasma amino acid levels which in turn modulate glucagon secretion from the pancreatic α-cell, thereby establishing a liver-α-cell axis described recently. We reported previously that the knock-in mice bearing homozygous V369M substitution (equivalent to a naturally occurring mutation V368M in the human glucagon receptor, GCGR) led to hypoglycemia with improved glucose tolerance. They also exhibited hyperglucagonemia, pancreas enlargement and α-cell hyperplasia. Here, we investigated the effect of V369M/V368M mutation on glucagon-mediated amino acid metabolism. It was found that GcgrV369M+/+ mice displayed increased plasma amino acid levels in general, but significant accumulation of the ketogenic/glucogenic amino acids was observed in animals fed with a high-fat diet (HFD), resulting in deleterious metabolic consequence characteristic of α-cell proliferation and hyperglucagonemia.

Keywords: V369M; glucagon receptor; mouse model; mutation; proliferation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acids / blood*
  • Animals
  • Cell Proliferation
  • Gene Knock-In Techniques
  • Genotype
  • Glucagon / blood*
  • Glucagon-Secreting Cells / metabolism*
  • Glucagon-Secreting Cells / pathology
  • Homozygote
  • Liver / metabolism*
  • Liver / pathology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Mutation*
  • Phenotype
  • Receptors, Glucagon / genetics*
  • Receptors, Glucagon / metabolism

Substances

  • Amino Acids
  • Receptors, Glucagon
  • Glucagon